These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 18567867)

  • 1. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis.
    Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH
    Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
    Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
    Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
    J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
    Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
    Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
    Berman PW; Heinemann SF
    J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenic antibodies in myasthenia gravis].
    Motomura M
    Brain Nerve; 2010 Apr; 62(4):411-8. PubMed ID: 20420182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
    Lindstrom J; Einarson B
    Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):169-73, 189. PubMed ID: 1889330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of myasthenia gravis antibodies to different acetylcholine receptor preparations.
    Zielinski A; Brenner T; Abramsky O
    Isr J Med Sci; 1982 Apr; 18(4):483-6. PubMed ID: 7085248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.